Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors Ended

2022-502867-39-00 Advanced solid tumors including non-small cell lung can 1 2023-09-29
Phase II trial of trastuzumab deruxtecan in first-line treatment HER2-positive locally advanced or metastatic breast cancer (MBC) patients c… Ended

2023-503627-26-00 Metastatic breast cancer 4 2023-09-28
Phase II, multi‑cohort trial of neoadjuvant and post‑surgery IO102‑IO103 and pembrolizumab in patients with selected resectable tumors Ended

2022-502787-20-00 Melanoma and squamous cell carcinoma of the head and ne 4 2023-09-28
A Phase 1 Study of PRT3789 in Participants with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation Ended

2022-502850-14-00 gastroesophageal junction 1 2023-09-25
A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Pa… Ended

2023-508489-14-00 Solid Tumors 4 2023-09-18
Oral fluorescent tracer administration to detect of early esophageal adenocarcinomas Ended

2023-503801-12-00 Barrett's esophagus 4 2023-09-15
A Phase 1 Study of BMS-986360/CC-90001 Alone and in Combination with Chemotherapy or Nivolumab in Advanced Solid Tumors Ended

2022-500930-27-00 Solid Tumor 3 2023-09-15
A study in healthy men to test whether carbamazepine influences the amount of BI 1810631 in the blood Ended

2022-503046-50-00 Healthy volunteer trial 3 2023-09-11
A study to investigate response to ompenaclid combined with FOLFIRI plus bevacizumab in patients with advanced or metastatic colorectal canc… Ended

2023-503356-27-00 Metastatic colorectal cancer that is resistant to the c 4 2023-09-07
Phase 3 Study Comparing Zimberelimab with Domvanalimab to Pembrolizumab in Advanced Non-Small Cell Lung Cancer Ended

2022-503071-28-00 Squamous Non-small cell Lung Cancer 5 2023-08-31
INCB 39110-801 A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Stu… Ended

2022-501661-47-00 Myelofibrosis ; postlung transplant (BOS); chronic graf 4 2023-08-23
Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer Ended

2022-502196-31-00 Advanced or Recurrent Endometrial Cancer 10 2023-08-21
A Study to Estimate the Effect of Multiple Doses of Carbamazepine on the PK of Single Dose Vepdegestrant in Healthy Adult Participants Ended

2023-505881-27-00 ER+/HER2 positive breast cancer 3 2023-08-14
A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 as single-agent and combination therapy in subjects with i… Ended

2023-508267-69-00 Subjects with Aadvanced solid tumors for whom life-prol 3 2023-08-11
68Ga satoreotide trizoxetan PET/CT in patients with high grade neuroendocrine lung cancer Ended

2023-503362-24-01 large cell neuroendocrine lung cancer 4 2023-08-09
MK-5684 Food Effect Study Ended

2023-505521-14-00 refractory metastatic prostate cancer 3 2023-08-02
A study of HFB200603 as a single agent and in combination with Tislelizumab in patients with advanced solid tumors Ended

2022-502891-22-00 Advanced Solid Tumors 1 2023-08-02
A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV … Ended

2022-502620-49-00 Resected Melanoma Stage III or Stage IV 2 2023-08-01
Clinical trial of MK-7648A in adults and children with skin cancer Ended

2022-501417-31-01 melanoma 5 2023-08-01
Multicentric randomized phase I/IIa trial of the safety and immunogenicity of a therapeutic HPV DC targeting vaccine in patients with Human … Ended

2022-502930-25-00 reduced risk of relapse of HPV-related oropharyngeal sq 7 2023-07-31
A Multicenter, Open-label Phase 1/2 Study of TYRA 300 in Advanced Urothelial Carcinoma and Other Solid Tumors Ended

2023-507589-22-00 Advanced Urothelial Carcinoma and Other Solid Tumors wi 7 2023-07-28
HU-F-AIM - A prospective, interventional clinical study to evaluate hydroxyurea (HU) resistance in patients with polycythaemia vera who meet… Ended

2022-502338-20-00 Polycythemia vera 6 2023-07-28
A Study of TAK-676 as Single Agent and TAK-676 in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Ended

2023-505627-30-00 Solid Neoplasm 7 2023-07-26
A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women. Ended

2023-503948-13-00 Healthy Post-menopausal women. 3 2023-07-20